Latest Litigation News

Page 8 of 26
ResMed Inc. reported robust financial results for Q2 FY2026, driven by strong demand in its Sleep and Breathing Health and Residential Care Software segments. The company also navigates ongoing patent litigation while maintaining solid liquidity and shareholder returns.
Ada Torres
Ada Torres
2 Feb 2026
ADX Energy reported a 24% drop in production due to mechanical issues but is advancing well workovers and new drilling, supported by a $3.5 million capital raise and plans for a dual listing in Oslo.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Ovanti Limited advances its U.S. buy now, pay later ambitions through strategic partnerships and a proposed Nasdaq listing valued at US$300 million.
Victor Sage
Victor Sage
30 Jan 2026
Zuleika Gold has resolved its long-running litigation with Catalyst Metals, receiving $46 million in cash and shares, with a further $2 million due soon. The company also upgraded its gold resources significantly, positioning itself for aggressive development and exploration.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Bathurst Resources reported a first-half FY26 EBITDA of NZD 16 million, maintaining its full-year guidance despite export challenges and cost pressures. Key development projects in New Zealand and Canada continue to advance steadily.
Maxwell Dee
Maxwell Dee
30 Jan 2026
ioneer Ltd has raised approximately US$50.4 million through an institutional placement to fund the advancement of its Rhyolite Ridge lithium-boron project in Nevada towards a Final Investment Decision in the second half of 2026. The capital injection supports project readiness, environmental permitting, and early works for this strategically significant US critical minerals asset.
Maxwell Dee
Maxwell Dee
30 Jan 2026
Lloyds Banking Group reported a robust 2025 performance with a 12% rise in statutory profit before tax and upgraded its 2026 guidance, underpinned by strong loan growth and digital innovation. The Group also announced significant shareholder returns totalling £3.9 billion, including dividends and a share buyback programme.
Claire Turing
Claire Turing
29 Jan 2026
Mayne Pharma delivered a robust FY25 performance with a 105% surge in underlying EBITDA and launched key dermatology products as it outlines a strategic growth path for FY26.
Victor Sage
Victor Sage
29 Jan 2026
St Barbara Limited reports strong feasibility outcomes for its New Simberi Gold Project and Nova Scotia developments, backed by significant strategic investments and regulatory approvals.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Auric Mining Limited has reported a standout December quarter, delivering strong gold production and cashflow from its Munda Gold Mine while advancing key projects at Burbanks and Lindsay’s.
Maxwell Dee
Maxwell Dee
28 Jan 2026
Energy Transition Minerals Ltd (ETM) reported key progress in its December 2025 quarter, including legal developments for its Greenland rare earth project, advancing a strategic mine acquisition in Spain, and moves toward a US Nasdaq listing.
Maxwell Dee
Maxwell Dee
27 Jan 2026
Cyclopharm Limited confirms its insurer has assumed responsibility for defending the company in ongoing legal proceedings initiated by 4DMedical Limited. This development marks a significant step in managing the dispute’s financial and operational risks.
Ada Torres
Ada Torres
27 Jan 2026